Advanced in Toxic Megacolon

Neill J. Adhikari

Toronto, ON, CA 
Advanced in Toxic Megacolon
Toronto, ON, CA 
OverviewLocationsClinical Research

Overview

Neill Adhikari practices in Toronto, Canada. Mr. Adhikari is rated as an Advanced expert by MediFind in the treatment of Toxic Megacolon. His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), Sepsis, Low Blood Pressure, and Toxic Megacolon.

His clinical research consists of co-authoring 216 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Toxic Megacolon.

Gender
Male

Locations

Toronto, ON, Canada
Other Locations
Toronto, Canada
Sherbrooke, QC, Canada
St. Michael's Hospital, Unity Health Toronto St. Michael's Hospital, Ottawa, ON, Canada
St. Joseph's Healthcare Hamilton, Ottawa, the Massawippi Valley Foundation, Ayer's Cliff, CHU Dr. Georges L. Dumont, Island Health Authority, Halton Healthcare
Oakville, ON, Canada
St. Michael's Hospital and the University of Toronto, St. Michael's Hospital
London, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
STandard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial (Principal Trial)
Enrollment Status: Completed
Publish Date: October 18, 2024
Intervention Type: Other
Study Phase: Not Applicable
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19
Enrollment Status: Completed
Publish Date: December 13, 2023
Intervention Type: Drug, Other
Study Drug: Peginterferon Lambda-1A
Study Phase: Phase 2
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT)
Enrollment Status: Completed
Publish Date: December 17, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 2 Less Clinical Trials

214 Total Publications

Reply to Wang et al.: Closing the Gaps: Enhancing Risk Factor Evaluation for Patient-Important Upper Gastrointestinal Bleeding.
Reply to Wang et al.: Closing the Gaps: Enhancing Risk Factor Evaluation for Patient-Important Upper Gastrointestinal Bleeding.
Journal: American journal of respiratory and critical care medicine
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Adhikari's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile